Creatine and Creatinine Metabolism - Physiological Reviews

1190 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
H.-U. Aeschbacher, J. S. Felton, and S. Sato. New York: Wiley-Liss,
1990, p. 19–38.
238. FELTON JS, KNIZE MG, ROPER M, FULTZ E, SHEN NH, AND
TURTELTAUB KW. Chemical analysis, prevention, and low-level
dosimetry of heterocyclic amines from cooked food. Cancer Res
52 Suppl: 2103s–2107s, 1992.
239. FELTON JS, KNIZE MG, SHEN NH, ANDRESEN BD, BJELDANES
LF, AND HATCH FT. Identification of the mutagens in cooked beef.
Environ Health Perspect 67: 17–24, 1986.
240. FENG Y-J, CHEN C, FALLON JT, LAI T, CHEN L, KNIBBS DR,
WATERS DD, AND WU AHB. Comparison of cardiac troponin I,
creatine kinase-MB, and myoglobin for detection of acute ischemic
myocardial injury in a swine model. Am J Clin Pathol 110:
70–77, 1998.
241. FIELD ML. Creatine supplementation in congestive heart failure.
Cardiovasc Res 31: 174–175, 1996.
242. FIELD ML, CLARK JF, HENDERSON C, SEYMOUR A-ML, AND
RADDA GK. Alterations in the myocardial creatine kinase system
during chronic anaemic hypoxia. Cardiovasc Res 28: 86–91, 1994.
243. FINKELSTEIN JD. Methionine metabolism in mammals: the biochemical
basis for homocystinuria. Metabolism 23: 387–398, 1974.
244. FISKE CH AND SUBBAROW Y. The nature of the “inorganic phosphate”
in voluntary muscle. Science 65: 401–403, 1927.
245. FITCH CD. Significance of abnormalities of creatine metabolism.
In: Pathogenesis of Human Muscular Dystrophies, edited by L. P.
Rowland. Amsterdam: Excerpta Medica, 1977, p. 328–340.
246. FITCH CD AND CHEVLI R. Inhibition of creatine and phosphocreatine
accumulation in skeletal muscle and heart. Metabolism 29:
686–690, 1980.
247. FITCH CD, CHEVLI R, AND JELLINEK M. Phosphocreatine does
not inhibit rabbit muscle phosphofructokinase or pyruvate kinase.
J Biol Chem 254: 11357–11359, 1979.
248. FITCH CD, HSU C, AND DINNING JS. The mechanism of kidney
transamidinase reduction in vitamin E-deficient rabbits. J Biol
Chem 236: 490–492, 1961.
249. FITCH CD, JELLINEK M, AND MUELLER EJ. Experimental depletion
of creatine and phosphocreatine from skeletal muscle. J Biol
Chem 249: 1060–1063, 1974.
250. FITCH CD AND SHIELDS RP. Creatine metabolism in skeletal
muscle. I. Creatine movement across muscle membranes. J Biol
Chem 241: 3611–3614, 1966.
251. FITCH CD, SHIELDS RP, PAYNE WF, AND DACUS JM. Creatine
metabolism in skeletal muscle. III. Specificity of the creatine entry
process. J Biol Chem 243: 2024–2027, 1968.
252. FLAHERTY JT, WEISFELDT ML, BULKLEY BH, GARDNER TJ,
GOTT VL, AND JACOBUS WE. Mechanisms of ischemic myocardial
cell damage assessed by phosphorus-31 nuclear magnetic
resonance. Circulation 65: 561–571, 1982.
253. FLAMENG W, ANDRES J, FERDINANDE P, MATTHEUSSEN M,
AND VAN BELLE H. Mitochondrial function in myocardial stunning.
J Mol Cell Cardiol 23: 1–11, 1991.
254. FLAMENG W, DYSZKIEWICZ W, AND MINTEN J. Energy state of
the myocardium during long-term cold storage and subsequent
reperfusion. Eur J Cardio-thor Surg 2: 244–255, 1988.
255. FLISINSKA-BOJANOWSKA A. Effects of oral creatine administration
on skeletal muscle protein and creatine levels. Biol Sport 13:
39–46, 1996.
256. FONTANET HL, TRASK RV, HAAS RC, STRAUSS AW, ABENDS-
CHEIN DR, AND BILLADELLO JJ. Regulation of expression of M,
B, and mitochondrial creatine kinase mRNAs in the left ventricle
after pressure overload in rats. Circ Res 68: 1007–1012, 1991.
257. FORDE A AND JOHNSON DB. Preliminary studies on enzymes of
creatinine degradation. Biochem Soc Trans 2: 1342–1344, 1974.
258. FOSSATI P, PONTI M, PASSONI G, TARENGHI G, MELZI D’ERIL
GV, AND PRENCIPE L. A step forward in enzymatic measurement
of creatinine. Clin Chem 40: 130–137, 1994.
259. FOSSEL ET AND HOEFELER H. Complete inhibition of creatine
kinase in isolated perfused rat hearts. Am J Physiol Endocrinol
Metab 252: E124–E129, 1987.
260. FOUGEROUSSE F, BROUX O, RICHARD I, ALLAMAND V,
PEREIRA DE SOUZA A, BOURG N, BRENGUIER L, DEVAUD C,
PASTURAUD P, ROUDAUT C, CHIANNILKULCHAï N, HILLAIRE
D, BUI H, CHUMAKOV I, WEISSENBACH J, CHERIF D, COHEN
D, AND BECKMANN JS. Mapping of a chromosome 15 region
involved in limb girdle muscular dystrophy. Hum Mol Genet 3:
285–293, 1994.
261. FRASER CL AND ARIEFF AI. Nervous system complications in
uremia. Ann Intern Med 109: 143–153, 1988.
262. FREYSSENET D, BERTHON P, BARTHÉLÉMY J-C, BUSSO T,
GEYSSANT A, AND DENIS C. Energetic status and mitochondrial
oxidative capacity of rat skeletal muscle in response to creatine
analogue ingestion. Biochim Biophys Acta 1228: 211–215, 1995.
263. FREYSSENET D, BERTHON P, GEYSSANT A, AND DENIS C. ATP
synthesis kinetic properties of mitochondria isolated from the rat
extensor digitorum longus muscle depleted of creatine with
�-guanidinopropionic acid. Biochim Biophys Acta 1186: 232–236,
1994.
264. FRIEDMAN DL AND PERRYMAN MB. Compartmentation of multiple
forms of creatine kinase in the distal nephron of the rat
kidney. J Biol Chem 266: 22404–22410, 1991.
265. FRIEDRICH J, APSTEIN CS, AND INGWALL JS. 31 P nuclear magnetic
resonance spectroscopic imaging of regions of remodeled
myocardium in the infarcted rat heart. Circulation 92: 3527–3538,
1995.
266. FRITSCHE E, HUMM A, AND HUBER R. The ligand-induced structural
changes of human L-arginine:glycine amidinotransferase.
J Biol Chem 274: 3026–3032, 1999.
267. FRITZ-WOLF K, SCHNYDER T, WALLIMANN T, AND KABSCH W.
Structure of mitochondrial creatine kinase. Nature 381: 341–345,
1996.
268. FUJIOKA M, KONISHI K, AND TAKATA Y. Recombinant rat liver
guanidinoacetate methyltransferase: reactivity and function of
sulfhydryl groups. Biochemistry 27: 7658–7664, 1988.
269. FUJIOKA M, TAKATA Y, AND GOMI T. Recombinant rat guanidinoacetate
methyltransferase: structure and function of the NH 2terminal
region as deduced by limited proteolysis. Arch Biochem
Biophys 285: 181–186, 1991.
270. FUJIOKA M, TAKATA Y, KONISHI K, GOMI T, AND OGAWA H.
Structure-function relationships of guanidinoacetate methyltransferase
as revealed by chemical modification and site-directed
mutagenesis of cysteine residues. In: Guanidino Compounds in
Biology and Medicine, edited by P. P. De Deyn, B. Marescau, V.
Stalon, and I. A. Qureshi. London: Libbey, 1992, p. 159–164.
271. FUJITSUKA N, YOKOZAWA T, OURA H, AKAO T, KOBASHI K,
IENAGA K, AND NAKAMURA K. L-Gulono-�-lactone oxidase is the
enzyme responsible for the production of methylguanidine in the
rat liver. Nephron 63: 445–451, 1993.
272. FUJITSUKA N, YOKOZAWA T, OURA H, NAKAMURA K, AND
IENAGA K. Major role of hydroxyl radical in the conversion of
creatinine to creatol. Nephron 68: 280–281, 1994.
273. FUNAHASHI M, KATO H, SHIOSAKA S, AND NAKAGAWA H.
Formation of arginine and guanidinoacetic acid in the kidney in
vivo. Their relations with the liver and their regulation. J Biochem
89: 1347–1356, 1981.
274. FUNANAGE VL, CARANGO P, SHAPIRO IM, TOKUOKA T, AND
TUAN RS. Creatine kinase activity is required for mineral deposition
and matrix synthesis in endochondral growth cartilage.
Bone Miner 17: 228–236, 1992.
275. FURTER R, FURTER-GRAVES EM, AND WALLIMANN T. Creatine
kinase: the reactive cysteine is required for synergism but is
nonessential for catalysis. Biochemistry 32: 7022–7029, 1993.
276. GANESAN V, JOHNSON A, CONNELLY A, ECKHARDT S, AND
SURTEES RAH. Guanidinoacetate methyltransferase deficiency:
new clinical features. Pediatr Neurol 17: 155–157, 1997.
277. GARD JK, KICHURA GM, ACKERMAN JJH, EISENBERG JD,
BILLADELLO JJ, SOBEL BE, AND GROSS RW. Quantitative 31 P
nuclear magnetic resonance analysis of metabolite concentrations
in Langendorff-perfused rabbit hearts. Biophys J 48: 803–813,
1985.
278. GAUGLITZ U. Anaerober mikrobieller Abbau von Kreatin,
Kreatinin und N-Methylhydantoin. Göttingen, Germany: Georg-
August-Universität, 1988.
279. GELFAND VI AND BERSHADSKY AD. Microtubule dynamics:
mechanism, regulation, and function. Annu Rev Cell Biol 7: 93–
116, 1991.
280. GELLERICH FN, LATERVEER FD, KORZENIEWSKI B, ZIERZ S,